People · Operator
Named in public records as an officer, director or promoter · active 2019–2023 · Other Technology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Longeviti Neuro Solutions, LLC | — | Other Technology | Series A | $23.0M | $5.5M | 2019 |
| Adaptilens, Inc. | — | Other Health Care | Series A | $8.6M | $36.0M | 2023 |
John Andres at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Andres on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jamie Goldstein | 1 | 12 |
| John Parker | 1 | 4 |
| Greg Cole | 1 | 4 |
| William Shea | 1 | 4 |
| Matthew B. Swartz | 1 | 2 |
| Chad Gordon | 1 | 2 |
| Jesse Christopher | 1 | 2 |
| Terry Kim | 1 | 2 |
| Robert Doris | 1 | 2 |
| Lewis Parker | 1 | 1 |
| Gregory B. Cole | 1 | 1 |
| Lewis B. Parker | 1 | 1 |
| John B. Andres | 1 | 1 |
| Jesse B. Christopher | 1 | 1 |
| C. Gianna Luca | 1 | 1 |
| Liane Clamen | 1 | 1 |
| Jill Kalmann | 1 | 1 |
| Jill Kalman | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.